(Q52107654)

22 April 2018

title

Is phencyclidine (PCP) abuse associated with organic mental impairment? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A539570

10 July 2022

Is Phencyclidine (PCP) Abuse Associated with Organic Mental Impairment? (English)

1 reference

https://api.crossref.org/works/10.3109/00952997909001717

2 July 2023

1 reference

2

Grant I

1 reference

22 April 2018

author name string

A. S. Carlin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A539570

10 July 2022

K. M. Adams

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A539570

10 July 2022

R. Reed

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A539570

10 July 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=539570

10 July 2022

publication date

1 January 1979

1 reference

22 April 2018

full work available at URL

http://www.tandfonline.com/doi/pdf/10.3109/00952997909001717

1 reference

https://api.crossref.org/works/10.3109/00952997909001717

American Journal of Drug and Alcohol Abuse

2 July 2023

published in

1 reference

22 April 2018

volume

6

1 reference

22 April 2018

issue

3

1 reference

22 April 2018

page(s)

273-281

1 reference

22 April 2018

https://api.crossref.org/works/10.3109%2F00952997909001717

1 reference

Clinical pharmacology of phencyclidine toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952997909001717

Observations on the psychotomimetic effects of Sernyl.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952997909001717

Phencyclidine ingestion: therapy review.

21 January 2018

7

1 reference

https://api.crossref.org/works/10.3109/00952997909001717

Neuropsychological and EEG disturbances in polydrug users

2 July 2023

11

1 reference

https://api.crossref.org/works/10.3109/00952997909001717

Hallucinogenic drugs and cerebral deficit

2 July 2023

13

1 reference

https://api.crossref.org/works/10.3109/00952997909001717

Organicity Measures Following Repeated LSD Ingestion

2 July 2023

15

1 reference

https://api.crossref.org/works/10.3109/00952997909001717

Repeated LSD ingestion and performance on neuropsychological tests

2 July 2023

16

1 reference

https://api.crossref.org/works/10.3109/00952997909001717

Preliminary investigations of the effects of Sernyl upon cognitive and sensory processes.

2 July 2023

19

1 reference

https://api.crossref.org/works/10.3109/00952997909001717

An investigation of drug induced sensory disturbances

2 July 2023

20

1 reference

https://api.crossref.org/works/10.3109/00952997909001717

Model psychoses and schizophrenia

2 July 2023

21

1 reference

https://api.crossref.org/works/10.3109/00952997909001717

Comparison of phencyclidine hydrochloride (Sernyl) with other drugs. Simulation of schizophrenic performance with phencyclidine hydrochloride (Sernyl), lysergic acid diethylamide (LSD-25), and amobarbital (Amytal) sodium; II. Symbolic and sequential

2 July 2023

22

1 reference

https://api.crossref.org/works/10.3109/00952997909001717

2 July 2023

Identifiers

1 reference

22 April 2018

1 reference

22 April 2018